Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

993 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators; International Breast Cancer Study Group. Pagani O, et al. Among authors: viale g. N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881463 Free PMC article. Clinical Trial.
Pre-operative chemotherapy and radiotherapy in breast cancer.
Colleoni M, Nole F, Minchella I, Noberasco C, Luini A, Orecchia R, Veronesi P, Zurrida S, Viale G, Goldhirsch A. Colleoni M, et al. Among authors: viale g. Eur J Cancer. 1998 Apr;34(5):641-5. doi: 10.1016/s0959-8049(97)10091-0. Eur J Cancer. 1998. PMID: 9713267
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group. Spataro VJ, et al. Among authors: viale g. Cancer. 2003 Apr 1;97(7):1591-600. doi: 10.1002/cncr.11224. Cancer. 2003. PMID: 12655514 Free article.
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER, Veronesi P, Torrisi R, Cazzaniga M, Mora S, Sandri MT, Pelosi G, Luini A, Goldhirsch A, Lien EA, Veronesi U. Decensi A, et al. Among authors: viale g. J Natl Cancer Inst. 2003 Jun 4;95(11):779-90. doi: 10.1093/jnci/95.11.779. J Natl Cancer Inst. 2003. PMID: 12783932 Free article. Clinical Trial.
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Colleoni M, Viale G, Zahrieh D, Pruneri G, Gentilini O, Veronesi P, Gelber RD, Curigliano G, Torrisi R, Luini A, Intra M, Galimberti V, Renne G, Nolè F, Peruzzotti G, Goldhirsch A. Colleoni M, et al. Among authors: viale g. Clin Cancer Res. 2004 Oct 1;10(19):6622-8. doi: 10.1158/1078-0432.CCR-04-0380. Clin Cancer Res. 2004. PMID: 15475452 Free article.
Prediction of cancer outcome with microarrays.
Goldhirsch A, Gelber RD, Viale G, Colleoni M, Coates AS. Goldhirsch A, et al. Among authors: viale g. Lancet. 2005 May 14-20;365(9472):1685-6; author reply 1686. doi: 10.1016/S0140-6736(05)66542-7. Lancet. 2005. PMID: 15894095 No abstract available.
Breast cancer.
Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Veronesi U, et al. Among authors: viale g. Lancet. 2005 May 14-20;365(9472):1727-41. doi: 10.1016/S0140-6736(05)66546-4. Lancet. 2005. PMID: 15894099 Review.
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
International Breast Cancer Study Group; Basser RL, O'Neill A, Martinelli G, Green MD, Peccatori F, Cinieri S, Coates AS, Gelber RD, Aebi S, Castiglione-Gertsch M, Viale G, Price KN, Goldhirsch A. International Breast Cancer Study Group, et al. Among authors: viale g. J Clin Oncol. 2006 Jan 20;24(3):370-8. doi: 10.1200/JCO.2005.03.5196. J Clin Oncol. 2006. PMID: 16421418 Clinical Trial.
993 results